FEP Blue (Federal Employee Program)

Data updated April 11, 2026

Nationwide federal-employee health benefits payer channel (Blue Cross Blue Shield FEP) with published pharmacy policy criteria for Spravato.

Reimbursement & Market Access Snapshot

Insurance Payers & Reimbursement Specialists

Service Model

Private / Commercial Payer

Jurisdiction

National

Coverage

1 country

Last Verified

Apr 11, 2026

Focus Areas

Coverage Policy DesignFormulary & Access CriteriaPayment Coding Pathways

Evidence Requirements

Clinical Efficacy EndpointsComparative EffectivenessLong-Term Safety

Market Access Notes

FEP Blue publishes pharmacy policy documents for Spravato as part of its federal employee benefits coverage framework.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Linked Stakeholders

Source Evidence

FEP Blue Pharmacy Policy: Spravato (esketamine nasal spray)

https://www.fepblue.org/-/media/PDFs/Medical-Policies/2025/March/Pharmacy-Policies/Remove-and-Replace/560033-Spravato-esketamine-nasal-spray.pdf

FEP Blue Pharmacy Prescriptions Resource

https://www.fepblue.org/pharmacy/prescriptions